ResMed | RMD - Current Liabilities


ResMed reported $1.4B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Ansell USD 468.9M 53.1M Dec/2025
Artivion USD 106.93M 14.23M Jun/2026
AtriCure USD 81.92M 8.72M Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Cochlear AUD 558.9M 43.4M Dec/2025
Cooper Companies USD 1.8B 209M Mar/2026
CSL USD 4.61B 207M Dec/2025
Dexcom USD 2.36B 133.9M Jun/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Fisher Paykel Healthcare NZD 497.8M 26.5M Jun/2026
Globus Medical USD 479.35M 3.12M Jun/2026
Haemonetics USD 263.24M 19.36M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
Intuitive Surgical USD 2.58B 65.1M Jun/2026
Medtronic USD 11.66B 2.16B Mar/2026
Philips EUR 7.42B 8M Jun/2026
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
ResMed USD 1.4B 43.9M Jun/2026
Sigma Healthcare AUD 1.7B 1.33B Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Steris USD 1.28B 138.3M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026